Stay updated on Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page.

Latest updates to the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page
- Check5 days agoChange DetectedThe clinical trial record for NCT03241173 is now available, with study details, results, eligibility criteria, locations, and supporting documents replacing the error page.SummaryDifference88%

- Check12 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA banner above the ClinicalTrials.gov error page announces NIH updates and says the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer’s site revision indicator changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error, restricting access to the study record content and leaving only the error message and site chrome visible.SummaryDifference22%

Stay in the know with updates to Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page.